One of the toughest challenges for all researchers in this area will be to comprehend a very un-predicted and sometimes even contradicting behavior of LCN2 in NAFLD-HCC pathology. This evidence concerns the gene LCN2 and metabolic dysfunction-associated steatotic liver disease.